The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
about
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacinComparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complexIn vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinoloneIn vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859aComparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacinCiprofloxacin-Induced Cytotoxicity and Apoptosis in HeLa Cells.Assessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis.Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents.Effect of bismuth subsalicylate on ciprofloxacin bioavailability.Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.Fluoroquinolones in pediatrics and their nephrotoxicity in adults: minireview.Early stage efficacy and toxicology screening for antibiotics and enzyme inhibitors.DNA gyrase: structure and function.Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections.Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis.Serum sickness-like illness associated with ciprofloxacin.Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens.Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.Activities of five new fluoroquinolones against Pseudomonas pseudomalleiEndogenous active efflux of norfloxacin in susceptible Escherichia coliIn vitro activities of amifloxacin and two of its metabolites.Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patientsEfficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.Concentration of norfloxacin in human gallbladder tissue and bile after single-dose oral administration.Penetration of enoxacin into bronchial secretions.Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.Pharmacokinetics of ofloxacin after parenteral and oral administrationComparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats
P2860
Q24670225-66E8C3DC-12E8-44CB-B4EE-25A12360EA1FQ28343858-C5D3AF50-EE29-492D-8EF2-E781CB57FA6FQ28359688-0146A287-9569-43F5-828B-BB36C0A4EE8FQ28368060-4988A7ED-F486-471B-827A-8B65EAE7C995Q28378625-FD6ED0C5-AAE2-4207-B3C0-848E173458DEQ33519665-DB953E34-9D6A-4FDD-899E-6793C6EAA3B5Q33696090-521C15FC-B856-4A48-9765-752323B6A488Q33742693-E8E3BAE2-E945-4EFD-ABD9-5E005F5FEFFAQ33748723-DF09D51C-FF35-46A1-B245-5DCEC93B8444Q33759632-1F39A980-0746-458D-ABD0-3495569380A8Q33867704-5EF41C43-B513-460F-B740-5629AA4DB74FQ33893117-C23A1E90-3CE6-4572-BCE3-6DC006ABC707Q33956898-7663CCF9-64F5-4ADB-9AD1-9E288ABC438FQ34213192-4CE2F1E4-362C-4C0B-99E0-4A62C7DFD41AQ34507230-45018045-5929-4717-AAB2-2B00C40A4026Q34537808-560C4F20-27C6-4A3F-8FF9-EFE63C45F4DBQ34687048-1382DB76-A396-4BAA-9B23-68872ACB5990Q35138544-162B0685-A243-45BC-AB03-F095148FFAC6Q35139147-9E6ED27C-DBDB-4417-82F9-AFD67498A22EQ35243711-612490D9-A0D1-4D15-BB01-6B5E288F24FDQ35245010-3AA0A315-E175-46A8-B09D-3A84E932A14DQ35248737-4E6F2967-84AE-4707-907A-FE7FB431041EQ35250729-ED60F522-715B-413B-B1A4-13870C5D7046Q35253998-93C4F586-DE0B-425D-A371-F15F1D47EED1Q35255146-E3B606F8-0B85-4513-8FD1-4B9B35E6F59AQ35283618-C8CAAAC1-58D7-4BBC-923E-FAD9080419B6Q35284580-ACAAD98F-CA84-49F5-B714-6B6D1FE0F465Q35284671-42FA12DF-8D6A-4B82-9AB0-63BEE9955BD8Q35310408-1DC79089-0205-4FC5-B8AF-73058D8C6C2FQ35317399-88FAA5B4-9CDA-40BC-8F24-777034513EE9Q35334146-2D78D16D-5545-41B7-BCD1-F1A858E332FBQ35353461-6AA96FE6-6333-4B47-ADD6-EA8AADDA2E98Q35354413-510FB161-20B6-40DF-8800-B370E0D9A883Q35536165-A0E54465-5665-4D5A-9E17-23C7C122229BQ35536186-F691DB6F-BD80-4737-B420-096FEA602F01Q35537328-F8005023-F70C-403C-9A08-3B8DC4888297Q35540058-08E9A204-3097-4441-9871-F976EACDE179Q35541070-3866D28A-EB12-44FD-B93D-A334A5F8027FQ35541436-EBF7168A-A393-41BC-80B6-E9468F013CE4Q35543546-1751D438-F171-4D5F-A643-85D8EDAD1834
P2860
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@ast
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@en
type
label
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@ast
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@en
prefLabel
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@ast
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@en
P2860
P356
P1476
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
@en
P2093
P2860
P304
P356
10.1128/AAC.28.5.716
P407
P577
1985-11-01T00:00:00Z